Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient.

Détails

ID Serval
serval:BIB_4DA875C8C3D4
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Titre
Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient.
Périodique
Open forum infectious diseases
Auteur⸱e⸱s
Jent P., Trippel M., Frey M., Pöllinger A., Berezowska S., Langer R., Furrer H., Béguelin C.
ISSN
2328-8957 (Print)
ISSN-L
2328-8957
Statut éditorial
Publié
Date de publication
11/2018
Peer-reviewed
Oui
Volume
5
Numéro
11
Pages
ofy244
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
We report the case of a young patient treated with rituximab-containing chemotherapy who was infected with measles despite previous vaccination. Treatment with vitamin A, ribavirin, and immunoglobulins was started; nevertheless he developed severe pneumonitis and deceased. Broad vaccination coverage is crucial in protecting vulnerable subjects.
Mots-clé
immunocompromised, measles, rituximab, vaccination
Pubmed
Web of science
Open Access
Oui
Création de la notice
29/06/2020 12:43
Dernière modification de la notice
30/06/2020 6:26
Données d'usage